Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free LABS Stock Alerts

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.08 -0.01 (-6.25%)
As of 07/24/2026 11:56 AM Eastern
Compare

LABS vs. CWEB, TGOD, NINE, WMD, and DB

Should you buy MediPharm Labs stock or one of its competitors? MarketBeat compares MediPharm Labs with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MediPharm Labs include Charlotte's Web (CWEB), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), WeedMD (WMD), and Decibel Cannabis (DB). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does MediPharm Labs compare to Charlotte's Web?

Charlotte's Web (TSE:CWEB) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

MediPharm Labs has lower revenue, but higher earnings than Charlotte's Web. MediPharm Labs is trading at a lower price-to-earnings ratio than Charlotte's Web, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebC$48.79M1.86-C$25.55M-C$0.23N/A
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

1.2% of Charlotte's Web shares are held by institutional investors. Comparatively, 0.3% of MediPharm Labs shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by insiders. Comparatively, 4.5% of MediPharm Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

MediPharm Labs has a net margin of -20.21% compared to Charlotte's Web's net margin of -74.93%. MediPharm Labs' return on equity of -23.55% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Charlotte's Web-74.93% -2,056.41% -17.25%
MediPharm Labs -20.21%-23.55%-7.17%

In the previous week, Charlotte's Web's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
Charlotte's Web Neutral
MediPharm Labs Neutral

Charlotte's Web has a beta of 1.013931, meaning that its share price is 1% more volatile than the broader market. Comparatively, MediPharm Labs has a beta of -0.528174, meaning that its share price is 153% less volatile than the broader market.

Summary

Charlotte's Web beats MediPharm Labs on 6 of the 11 factors compared between the two stocks.

How does MediPharm Labs compare to Green Organic Dutchman?

MediPharm Labs (TSE:LABS) and Green Organic Dutchman (TSE:TGOD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A
Green Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/A

In the previous week, MediPharm Labs' average media sentiment score of 0.00 equaled Green Organic Dutchman'saverage media sentiment score.

Company Overall Sentiment
MediPharm Labs Neutral
Green Organic Dutchman Neutral

Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
Green Organic Dutchman N/A N/A N/A

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

MediPharm Labs beats Green Organic Dutchman on 5 of the 9 factors compared between the two stocks.

How does MediPharm Labs compare to Delta 9 Cannabis?

Delta 9 Cannabis (CVE:NINE) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

In the previous week, Delta 9 Cannabis' average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
Delta 9 Cannabis Neutral
MediPharm Labs Neutral

Delta 9 Cannabis has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Delta 9 Cannabis' return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Delta 9 CannabisN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Delta 9 Cannabis has higher earnings, but lower revenue than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than Delta 9 Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$12.87M6.94C$4.69MC$0.0519.07
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

Summary

Delta 9 Cannabis beats MediPharm Labs on 7 of the 10 factors compared between the two stocks.

How does MediPharm Labs compare to WeedMD?

WeedMD (CVE:WMD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

MediPharm Labs has higher revenue and earnings than WeedMD. MediPharm Labs is trading at a lower price-to-earnings ratio than WeedMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WeedMDC$27.53M2.46-C$102.60M-C$0.42N/A
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

In the previous week, WeedMD's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
WeedMD Neutral
MediPharm Labs Neutral

WeedMD has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. WeedMD's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
WeedMDN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

Summary

WeedMD and MediPharm Labs tied by winning 5 of the 10 factors compared between the two stocks.

How does MediPharm Labs compare to Decibel Cannabis?

Decibel Cannabis (CVE:DB) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Decibel Cannabis has a net margin of -3.78% compared to MediPharm Labs' net margin of -20.21%. Decibel Cannabis' return on equity of -1.05% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Decibel Cannabis-3.78% -1.05% 3.04%
MediPharm Labs -20.21%-23.55%-7.17%

0.7% of Decibel Cannabis shares are held by institutional investors. Comparatively, 0.3% of MediPharm Labs shares are held by institutional investors. 1.1% of Decibel Cannabis shares are held by insiders. Comparatively, 4.5% of MediPharm Labs shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Decibel Cannabis has higher revenue and earnings than MediPharm Labs. Decibel Cannabis is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Decibel CannabisC$121.32M0.50-C$1.03M-C$0.01N/A
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

Decibel Cannabis has a beta of -0.074057, suggesting that its share price is 107% less volatile than the broader market. Comparatively, MediPharm Labs has a beta of -0.528174, suggesting that its share price is 153% less volatile than the broader market.

Decibel Cannabis currently has a consensus price target of C$0.18, indicating a potential upside of 66.67%. Given Decibel Cannabis' stronger consensus rating and higher possible upside, research analysts clearly believe Decibel Cannabis is more favorable than MediPharm Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Decibel Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
MediPharm Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Decibel Cannabis' average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
Decibel Cannabis Neutral
MediPharm Labs Neutral

Summary

Decibel Cannabis beats MediPharm Labs on 12 of the 15 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

Export
MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$33.99MC$2.25BC$6.88BC$12.48B
Dividend YieldN/A2.81%2.67%6.19%
P/E Ratio-3.755.0427.0836.95
Price / Sales0.741,642.24495.869.44
Price / Cash1.3010.1850.5482.29
Price / Book0.919.9110.284.39
Net Income-C$12.05MC$20.27BC$3.60BC$299.09M
7 Day PerformanceN/A-0.89%-1.27%0.61%
1 Month PerformanceN/A0.06%-0.36%1.06%
1 Year PerformanceN/A7.14%18.31%30.89%

MediPharm Labs Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.08
-6.3%		N/A+7.1%C$33.99MC$43.28MN/A130
CWEB
Charlotte's Web
N/AC$0.47
+4.5%		N/A+179.2%C$125.81MC$48.79MN/A164
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37MN/A41
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%		N/A+0.0%C$89.36MC$12.87M19.07940
WMD
WeedMD
N/AC$0.28
-1.8%		N/A+0.0%C$67.82MC$27.53MN/A628

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:LABS) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel